-
-
Call more information
660-596-2224 -
The US Food and Drug Administration (FDA) has approved an abuse-deterrent extended-release formulation of oxycodone (Targiniq ER, Purdue Pharma LP), a combination of oxycodone hydrochloride and naloxone hydrochloride, the agency announced today. The new formulation is approved to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment, for which alternative treatment options are […]
Read MoreStan Xuhui Li, MD, of Hamilton, New Jersey, was a full-time anesthesiologist at a local hospital who had a sideline. On weekends, the 60-year-old Dr. Li saw patients in a pain-management clinic 80 miles away in the Queens borough of New York City. A jury in a New York state court concluded on July 18 […]
Read MoreEvery leader is a coach to those who look to them for guidance. Your job as a leader is to be there when one of your employees are in a rut, but if you consistently offer them a gift-wrapped solution, those employees will forfeit their problem-solving skills in the process. Eventually, a new problem manifests […]
Read MoreOctober 1st, 2015, is the deadline for healthcare providers to implement the twice-delayed ICD-10 code set, federal officials confirm. HHS will release the final rule, Administrative Simplification: Change to the Compliance Date for the International Classification of Diseases, 10th Revision (ICD–10–CM and ICD-10-PCS) Medical Data Code Sets, in the Federal Register August 4. The one-year […]
Read MorePublished in Oral Oncol. 2014 Jul 4. pii: S1368-8375(14)00172-9 Authors: Bossi P et al BACKGROUND: Painful mucositis is one of the most distressing toxicities of chemoradiotherapy (CRT) for head and neck cancer (HNC), with the characteristics of incidental predictable breakthrough pain (BTP) during swallowing. Fentanyl pectin nasal spray (FPNS) could be a good therapeutic option. […]
Read MoreAbuse-deterrent single-entity hydrocodone products are edging closer to market. Purdue Pharma LP has announced that the US Food and Drug Administration (FD) has granted Priority Review designation for its once-daily single-entity hydrocodone bitartrate tablet, an investigational pain medication formulated to make the product more difficult to misuse or abuse though chewing, snorting, and intravenous injection. […]
Read MoreThese six tips will help you combat boredom in your workplace, too. 1. Teach people how to treat you As an executive or manager, if you micromanage and focus only on your specific tasks, your team will reflect and replicate that type of work environment, which can easily bore people. Keep people from falling into […]
Read MoreAnesthesia providers miss chances to clean their hands during surgical procedures and have low hand-hygiene compliance according to a study published in the American Journal of Infection Control. Researchers from Dartmouth-Hitchcock Medical Center used intraoperative video observation to map the temporal patterns of anesthesia providers’ hand contact with the anesthesia work environment. They assessed hand-hygiene […]
Read MoreSome 15% of U.S. Army infantry soldiers who’ve recently returned from Iraq or Afghanistan say they’ve used opioids in the past month, with nearly half of these reporting no pain or only mild symptoms, according to a research letter in JAMA Internal Medicine. Nearly 2600 soldiers completed surveys roughly 3 months after returning from active […]
Read MoreFathalla Mashali, MD, accused of bilking Medicare A New England anesthesiologist stands high above all others in Medicare’s recently released list of how much money it pays providers, and court records help explain why he posted Ruthian numbers in a league of mostly singles hitters. According to records the Centers for Medicare & Medicaid Services […]
Read More